SUN’IY INTELLEKT TIBBIY XIZMATLAR SIFATINI OSHIRISHDA: MANBALAR ASOSIDA TAHLIL
Keywords:
Sun`iy intelekt, rentgen nurlari, kompyuter tomografiyasi, diagnostika, Google Health, IBM Watson Health, shaxsiylashtirilgan davolash, robotik jarrohlik, Da Vinchi.Abstract
Sun’iy intellekt (SI) texnologiyalari tibbiyot va diagnostika
sohalarida tub o‘zgarishlarni yuzaga keltirib, tashxis qo‘yish, davolash jarayonlarini
rejalashtirish hamda bemorlarni boshqarish samaradorligini oshirish uchun yangi
imkoniyatlar yaratmoqda. Mazkur maqolada tibbiyotda sun’iy intellektning asosiy
qo‘llanilish yo‘nalishlari tahlil qilinadi. Shuningdek, SI ning tezkor ma’lumotlarni
qayta ishlash va yuqori aniqlik kabi afzalliklari bilan bir qatorda, axloqiy masalalar,
inson omilining qisqarishi va texnologiyaga bog‘liqlik kabi mavjud cheklovlari ham
muhokama etiladi.
References
1. Masharipov U. “SUN’IY INTELLEKTNING MEDITSINADAGI O‘RNI” Journal
of universal science research. Volume-3, Issue-4
3. Xursanov Sh.U, Aliyev Sh.N. “TIBBIYOTDA SUN’IY INTELLEKTNING O‘RNI
VA AXAMIYATI” Journal of universal science research. VOLUME-2, ISSUE-12
4.
To‘xtaxo‘jaeva F.Sh., Imanova L.N. TIBBIY TASVIRLASHDA SUN’IY
INTELLEKT (SI)
5. Narzulloyeva F.Sh. SUN’IY INTELLEKTNING TIBBIYOTDAGI AHAMIYATI
Development of science Volume/ 4 ISSN 3030-3907
6. IBM Watson Health Reports (2024). “SI-Powered Medical Decision Support
Systems.”
7. Yala, A., Lehman, C., Schuster, T., Portnoi, T., & Barzilay, R. (2019). A deep
learning mammography-based model for improved breast cancer risk
prediction. Radiology, 292(1), 60-66.
8. Ardila, D., Kiraly, A. P., Bharadwaj, S., et al. (2019). End-to-end lung cancer
screening with three-dimensional deep learning on low-dose chest computed
tomography. Nature Medicine, 25(6), 954-961.
9. Esteva, A., Kuprel, B., Novoa, R. A., et al. (2017). Dermatologist-level classification
of skin cancer with deep neural networks. Nature, 542(7639), 115-118.
10. Ström, P., Kartasalo, K., Olsson, H., et al. (2020). Artificial intelligence for
diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic
study. The Lancet Oncology, 21(2), 222-232.
